Our experienced staff can test all hemp, CBD, and plant-based oil products, including raw plant material, extractions, infusions, and topicals. Visit our site to find out more. Leafly tested dozens of CBD products to see how the results stack up to what’s on the label. Our hemp & CBD product testing experts can help you navigate the evaluations required to meet state & federal regulations. Learn more about our CBD Lab.
Hemp & CBD Testing: Packages & Analyses
Since 1966, Badger Laboratories has provided our clients throughout United States with certified analytical services throughout multiple industries in our state-of-the-art laboratories. Our careful consultation and personal attention towards each client over the years has resulted in customer retention that we strongly value. Since 2019, our experienced staff has been dedicated to the Hemp and CBD market and can test all products including plant-based oil products, raw plant material, edibles, extractions, infusions, topicals and many other matrices. Standard turn-around time is 1-2 business days for potency and 3-5 business days for full panel testing upon arrival at our lab. We will match or beat any other labs pricing and discount bulk orders. We hope to hear from you and would be happy to serve you as one of our valued customers.
CANNABINOID PROFILE (POTENCY)
Badger Labs can analyze and report on your Certificate of Analysis that THC levels in Hemp and CBD products are at or below 0.3%. Your Certificate of Analysis will contain 11 cannabinoids including Total THC and CBD values.
Flower and Product testing both available. Testing includes: CBC, CBD, CBDA, CBDV, CBG, CBGA, CBN, THC-A, THCV, Δ8-THC and Δ9-THC, and are analyzed by Agilent 1220 Infinity II HPLC.
- Standard List: Includes As, Cd, Pb, Hg
- Full Scan: Includes 25 Metals
Heavy metal contamination can come from contaminated soil, fertilizers, or metals leached from the components in e-cigarettes or vaping pens. Using Inductively Coupled Plasma Mass Spectrometry (ICP/MS), we can analyze your CBD, hemp, and other plant-based products for toxic heavy metals including lead, arsenic, cadmium, and mercury.
Heavy metals are analyzed by Agilent ICP-MS.
Badger Labs can test for total microbial counts of E. coli, Yeast and Mold, Aerobic Plate Count, Total Enterobacteria, and Salmonella in flowers and CBD products.
Microbial impurities are analyzed by plate count.
In addition to its impact on the sample weight, the stability of cannabis, and its susceptibility to negative factors such as mold growth, is affected by the moisture content of the sample. Badger Labs can test the moisture content of your sample to ensure you’re getting the most accurate analysis.
Badger Labs can analyze and detect biological contamination in products from mycotoxins, including Aflatoxins and Ochratoxins.
Mycotoxins testing includes: Aflatoxin B1, B2, G1, G2 and Ochratoxin A, and is analyzed by Agilent Ultivo LC-QQQ.
Badger Labs testing meets or exceeds requirements for all states within the U.S. for potentially harmful chemicals including, insecticides, fungicides, and plant growth regulators. Seventy-two analytes from California’s regulatory list are included in the analysis.
Pesticides testing is analyzed by Agilent Ultivo LC-QQQ and includes:
- Carbaryl (Sevin)
- Dichlorvos (DDVP)
- Kresoxim methyl
- Methyl parathion
- Piperonyl butoxide
- Propoxur (Baygon)
Solvents can be introduced during the extraction or manufacturing of cannabis products. Badger Labs tests for all Category I and many Category II solvents.
Residual solvents testing is analyzed by Agilent Intuvo 9000 GCMS and includes:
Terpenes are important to the taste, smell, and stimulating effects of plant-based essential oils and other botanical products. Badger Labs tests for a comprehensive list of no less than 38 terpenes commonly found in cannabis plants and their related products.
Terpenes are analyzed by Agilent Intuvo 9000 GCMS and includes:
- Caryophyllene Oxide
- Fenchyl Alcohol
- Geranyl Acetate
- Sabinene Hydrate
CBD & HEMP PANEL
Full Panel includes:
- Cannabinoid Profile (Potency)
- Heavy Metals (Standard)
- Microbial Impurities
- Residual Solvents
*Custom panels can be quoted upon request
Samples can be delivered in-person to any of our 3 locations or shipped directly to our Stevens Point Laboratory. Download shipping instructions here. Standard turn-around time is 1-2 business days for potency and 3-5 business days for full panel testing. Please contact us at 715.544.4900 if you have questions or about the availability for expedited analysis.
Are you getting the CBD you paid for? We put 47 products to the test
Our national love affair with CBD has hit a rough spot. America, we have trust issues.
After a flurry of excitement about the wellness benefits of the newly legal cannabinoid, consumers are finding that all products are not created equal.
Some have too little CBD. Some have too much. Some have none at all.
CBD companies are thriving. But so are scammers and fraudsters. So we put 47 products to the test.
Congress’ decision to end federal CBD prohibition in late 2018 opened the door to hundreds of new companies marketing thousands of products. CBD soda, lip balm, gummies, vape pens, and capsules can now be found in supermarkets, gas stations, and drugstores across the United States.
CBD companies are thriving. But so are scammers and fraudsters.
“People have started to see the market grow and there are some fly-by-night companies trying to make a quick buck,” Marielle Weintraub, president of the US Hemp Authority, told the Associated Press recently.
So how can you sort the legit products from the junk?
The CBD industry is so new that most people don’t know which brands to trust. There’s no Apple, Coke, Gillette, or State Farm. Planet CBD is flat: All brands hold equal value in the minds of most consumers.
At Leafly, we were puzzled too. So we did something about it.
Take it to the lab
Over the past three months we worked with Confidence Analytics, a Washington state-licensed cannabis lab and founding partner of our Leafly Certified Labs Program, to test an array of CBD products. We wanted to see which brands delivered what they promised—and which did not.
Our three-part series starts here with a look at the test results from those 47 products. In part two, we examine why CBD is so challenging to deliver in exact doses, and in part three we offer seven tips for getting the CBD you paid for.
Test results: From zero CBD to way too much
Products delivering within 20% of advertised CBD are highlighted below:
Of 47 products tested, 24 delivered a reasonable amount of their promised dosage. Testing conducted by Confidence Analytics. (Leafly)
Is the label accurate?
The US Food and Drug Administration (FDA) is preparing to regulate CBD products, but until those rules are in place, CBD manufacturers are free to put whatever they want in their products.
The FDA is preparing CBD regulations, but until the rules are in place CBD makers can put whatever they want in their products.
A few sketchy operators have added synthetics like K2 or spice to CBD products, while others don’t bother to screen out pesticides or heavy metals.
In this unregulated era, label accuracy stands out as a first sign of quality. Industry experts we talked to were clear: If a company promises 300 mg of CBD and actually delivers 300 mg, it’s probably not cutting corners in other areas. Consumers, too, told us their first question is this: Am I actually getting CBD in this bottle?
So that’s where we started.
What we tested, and why
To find out who’s actually delivering the CBD promised on the label, we purchased 47 products from a variety of sources.
We noted the products that popped up in Google searches for terms like “best CBD products” and “cheap CBD,” and purchased many of them online. We picked up other products at national drugstore chains like Rite Aid and Walgreens.
We shopped independent grocery stores, convenience stores, and gas stations. We even found one product at a surf shop.
What we found
Here’s the good news: Most of our tested products actually delivered CBD. The bad news: Most products didn’t deliver the exact dosage promised. Some came close. Many were in the ballpark. A few straight-up cheated their customers.
Here’s how the data broke down:
- 51% of products (24 of 47) delivered the promised CBD within 20% of the labeled dosage.
- 23% of products (11 of 47) delivered some CBD, but less than 80% of the dosage promised on the label.
- 15% of products (7 of 47) delivered more than 120% of the promised CBD.
- 11% of products (5 of 47) delivered no CBD whatsoever.
State of the industry: Room for improvement
When it comes to today’s CBD products, very few manufacturers can precisely deliver the dosage promised on the label. CBD companies don’t advertise that, but it’s a fact.
This is also a fact: These products are getting better. Full federal legalization is only 11 months old and manufacturers are improving their processes every day.
In 2015, the FDA tested 18 CBD products. None contained CBD. In 2016, the FDA repeated the test with 22 products and found 77% contained little to no CBD whatsoever. Only four products even came close to delivering the labeled dose.
Today, more than half the products we tested delivered their labeled dose. It’s worth noting that “delivered” is a term of art. Almost no brand can produce absolutely perfect CBD dosage in every batch.
A fair benchmark
To be fair to the manufacturers, we adapted the FDA’s guidelines for label accuracy regarding small amounts of nutrients in dietary supplements, which is the category CBD products most clearly resemble.
The FDA considers a supplement misbranded if it delivers a nutrient at a dose at least 20% below or 20% above the value declared on its label.
A 20% label variance is a fair benchmark for CBD in 2019. But that’s not saying much.
We think that’s a fair standard for CBD in 2019. So for our purposes, a product that promises 300 mg of CBD but delivers 241 mg will be considered accurately labeled. A 300 mg product that delivers 239 mg will be considered mislabeled.
Is that an uncomfortably wide variance? Yes. If we paid for 300 mg and only got 241, we’d feel shortchanged. But right now, a 20% label variance is the best you’re going to get in the CBD space.
As the CBD industry matures, consumers should demand to an ever-closing gap between CBD promised and CBD delivered. And know this: A 20% label variance is not likely to fly with the feds. When FDA regulation of CBD arrives in 2020, federal rules will likely force these companies to deliver 100% of what they’re promising or go out of business.
The trends we discovered
As we sorted through the data, a number of trends stood out.
CBD tinctures and solid edibles are among the most reliable formats for delivering CBD, according to our test results. (Leafly)
Tinctures and gummies were the most reliable forms
All seven tinctures we tested delivered at least 85% of the label dosage. Five of the seven came within 10% of the promised dosage. With gummies, five of the six tested brands delivered at least 84% of the promised dosage. One brand only delivered 62%, while another brand delivered the promised 25 mg per gummy exactly.
Water was the least reliable form factor
Three of the four water brands we tested delivered no CBD at all. The fourth brand delivered only 70% of the CBD promised. Based on our tests, most “CBD water” should be more accurately labeled “water.”
Capsules delivered way more CBD than promised
All four CBD capsule products we tested contained more than 100% of the potency on the label. Three of the four tested at or above 140% of the label potency. That’s generous but not necessarily good. Patients using CBD for medical conditions need reliable dosages, not bonus CBD.
Vape pens and topicals were all over the board
The ten vape products we tested ranged from no CBD at all to 95% of the promised dosage. Two vape brands delivered less than 10% of their promised dosage. Six of the ten delivered less than 80% of the promised CBD. Topicals delivered a range of 37% to 152% of their promised CBD dosage. Three topicals delivered more CBD than promised, while three others delivered almost the exact dosage specified on the label.
“Hemp extract” doesn’t always mean CBD
CBD is no longer federally illegal, but it still exists in a murky legal space. Some brands are playing it safe by promising “hemp extract,” not CBD. Yet their labels use the same dosage metric as CBD (mg, or milligrams). That confuses consumers into believing they’re getting CBD when they may not be.
Further questions (and answers)
Now that you know the promise and perils of the CBD marketplace, you have questions. Like, why can’t more companies deliver consistent doses? How do I find the ones that do? In part two of our series, we take a look at why it’s so hard to deliver label-accurate CBD, while in part three we offer tips on how to make sure you get what you pay for.
Reliable CBD Product Testing: Regulation, Usage and Testing of Cannabis and Cannabinoids
Any discussion of cannabinoids must begin by defining the various terms which will be included in that discussion. Cannabis is a genus of flowering plants that are generally agreed to be comprised of three species: Cannabis sativa, Cannabis indica and Cannabis ruderalis.
Cannabinoids are naturally occurring constituents of the Cannabis plant which can be isolated for specific commercial and medicinal uses. Two of the most commonly discussed cannabinoids are 9-THC (Δ-9-tetrahydrocannabinol) and CBD (Cannabidiol).
Historically, the Cannabis genus of plants have been referred to by many names including “marijuana” and “hemp” but here in the US and especially since 2018, Industrial Hemp has been specifically defined (for regulatory purposes) as Cannabis sativa having a 9-THC content less than 0.3% (on the dried basis) which is sourced from a grower of Industrial Hemp licensed under the Agriculture Improvement Act of 2018 (better known as the 2018 Farm Bill, PL 115-334).
Federal Regulation of Cannabis and Cannabinoids
Prior to 2018, the US Department of Justice categorized all species of Cannabis and cannabinoids derived from them as Schedule I Controlled Substances, meaning they were categorized as being illegal substances having a high potential for abuse and no legitimate medical usage.
The 2018 Farm Bill removed Industrial Hemp (as defined above) from the Schedule I category of Controlled Substances, thereby opening the door for its usage in commercial applications. The Farm Bill however preserved the FDA’s authority over hemp products that fall under its jurisdiction.
Thus products that incorporate Industrial Hemp or cannabinoids derived from Industrial Hemp into their composition must meet any applicable FDA requirements and standards, just like any other FDA-regulated product.
Since the FDA has already approved a New Drug Application for a CBD drug product (Epidiolex) and has already approved several Investigational New Drug Applications for 9-THC, Section 201(ff)(3)(B) of the Food Drug and Cosmetic Act specifically forbids the usage of either CBD or 9-THC as dietary supplements or ingredients for human food or animal food.
Additionally, CBD and 9-THC may not be added to OTC drug products as active ingredients unless first approved by the FDA through a New Drug Application.
Except for CBD and 9-THC, the FDA does not currently restrict the use of any other cannabinoids derived from Industrial Hemp for use in human food or dietary supplements.
It should be noted that in December of 2018, the FDA granted GRAS (Generally Regarded As Safe) status to three hemp-seed derived ingredients for use in human food: hulled hemp seed, hemp seed protein powder, and hemp seed oil.
This decision was based upon the fact that the seeds of the hemp plant do not contain CBD or 9-THC.
State Regulation of Cannabis and Cannabinoids
At the State level, there is tremendous variation in the regulation of Cannabis and cannabinoids.
Some states have legalized all species of Cannabis and the cannabinoids derived from them for use as a medicine, recreational drug, food ingredient or dietary supplement.
Other states simply observe Federal law while others have adopted intermediate positions between total legalization and what Federal law currently allows regarding the use of Industrial Hemp.
This contradicting patchwork of Federal law and State regulations has given rise to many complications affecting members of the marijuana industry.
For example, some banks have adopted policies of not providing loans to industry members participating in activities beyond what Federal law currently allows, even if they are located within a state which has ‘legalized’ all Cannabis species; Some courts refuse to hear cases brought by industry members in attempts to recoup money owed them by vendors or client organizations since they are viewed as participating in “illegal” activities which violate Federal law.
Clearly, until there is a harmonization of Federal and State laws, this legal turmoil will continue to plague the marijuana industry.
Commercial Usage of Cannabis and Cannabinoids
Although Cannabis contains many cannabinoids, terpene compounds and other naturally occurring components of biological interest, 9-THC and CBD have thus far received the most interest for commercial applications.
In States where all species of Cannabis have been legalized, a wide range of products is offered which contain 9-THC and/or CBD including recreational drug “candies” (e.g., gummy bears), food or beverage items and even some dietary supplements – all in direct violation of Federal law and the Food, Drug and Cosmetic Act.
Of a far less controversial nature, many cosmetic and personal care products now include CBD derived from Industrial Hemp as a featured ingredient.
Dietary supplements free of CBD and 9-THC but containing other cannabinoids and components derived from Industrial Hemp (e.g., hemp seed oil) are legal in all jurisdictions and are also growing in popularity.
So What Can We Conclude From All of This?
- 9-THC and CBD are only two of the many cannabinoids naturally occurring in all species of the Cannabis plant.
- For regulatory purposes, Industrial Hemp is defined as the Cannabis species Cannabis sativa having a 9-THC content less than 0.3% (on the dried basis) which is sourced from a grower of Industrial Hemp licensed under the Agriculture Improvement Act of 2018 (better known as the 2018 Farm Bill, PL 115-334).
- Federal law allows the use of Industrial Hemp and constituents derived from it in a wide range of products, however, some uses are restricted by FDA.
- The Food, Drug and Cosmetic Actstrictly forbidsthe use of9-THC and/or CBD as dietary supplements and ingredients in human food, animal food and OTC Drugs. (Dietary supplements, human food, animal food and OTC Drugs may contain Industrial Hemp or components derived from Industrial Hemp so long as 9-THC and CBD have been excluded.)
- Cosmetic and Personal Care products may legally contain Industrial Hemp and its derivatives including CBDat any level and 9-THC below 0.3%.
- Contradictions between Federal and State laws have given rise to significant legal and business issues which currently plague the marijuana industry beyond the usage of Industrial Hemp in regulated products.
Let CPT℠ assist with your CBD Product Testing from your Cannabis-derived raw materials to the final Cannabinoid-containing products.
CPT℠ is an ISO/IEC 17025 accredited laboratory for conducting Cannabinoid Content Testing in raw materials and finished products. We can assist in determining the quality and legality of your raw materials and finished products regardless of their form.
Cosmetic/personal care products, foods, dietary supplements and beverages all fall within our area of expertise when testing for specific cannabinoids such as 9-THC and CBD or compiling a complete cannabinoid profile. Why not contact us today?